AtriCure
ATRC
212 hedge funds and large institutions have $3.49B invested in AtriCure in 2021 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 65 increasing their positions, 79 reducing their positions, and 20 closing their positions.
423% more call options, than puts
Call options by funds: $2.2M | Put options by funds: $420K
105% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 20
19% more capital invested
Capital invested by funds: $2.92B → $3.49B (+$568M)
11% more funds holding
Funds holding: 191 → 212 (+21)
0.75% less ownership
Funds ownership: 97.85% → 97.11% (-0.75%)
18% less repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 79
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$59.6M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
+$28.1M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$22.4M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$19.9M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$12.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$44.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$41.4M |
| 3 |
TCM
TimesSquare Capital Management
New York
|
-$19.4M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$18.6M |
| 5 |
BlackRock
New York
|
-$16.5M |
ATRC Hedge Fund Activity: Q2 2021 in Review
212 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q2 2021, worth a combined $3.49B — up 19% from $2.92B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new ATRC positions and 20 closed out — a net gain of 21 holders — while 65 added to existing stakes and 79 trimmed.
The largest buyer was Vanguard Group, adding an estimated $59.6M. The largest seller was Champlain Investment Partners, cutting an estimated $44.6M.
- 212 institutional investors held AtriCure (ATRC) as of Q2 2021, up from 191 in Q1 2021.
- Funds reported $3.49B of AtriCure stock for Q2 2021, up 19% quarter-over-quarter.
- 41 funds opened new AtriCure positions in Q2 2021 and 20 closed out, a net change of +21 holders.
- The largest AtriCure buyer in Q2 2021 was Vanguard Group, an estimated $59.6M added.
- The largest AtriCure seller in Q2 2021 was Champlain Investment Partners, an estimated $44.6M sold.
Based on aggregated 13F filings for Q2 2021.